PALISADE BIO, INC. Financing Cash Flow
PALISADE BIO, INC. (PALI) reported Financing Cash Flow of $3.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- PALISADE BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $147.00K, a 3575.00% increase year-over-year.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.13M.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $131.33M, a 3055.48% increase year-over-year.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.36M.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for fiscal 2025 was $134.44M, a 1303.05% increase from fiscal 2024.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for fiscal 2024 was $9.58M, a 14.34% decline from fiscal 2023.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for fiscal 2023 was $11.19M, a 26.69% decline from fiscal 2022.
- PALISADE BIO, INC. net cash provided by (used in) financing activities for fiscal 2022 was $15.26M, a 38.00% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $3.28M 10-Q · filed 2026-08-10 | $134.61M derived: sum of 3 quarters · filed 2026-08-10 | $137.97M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $3.13M 10-Q · filed 2026-05-12 | $134.46M derived: sum of 2 quarters · filed 2026-05-12 | $137.83M derived: sum of 3 quarters · filed 2026-05-12 | $137.83M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $131.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $134.69M derived: sum of 2 quarters · filed 2026-03-20 | $134.70M derived: sum of 3 quarters · filed 2026-08-10 | $134.44M 10-K · filed 2026-03-20 | |||
| 2025-09-30 | $3.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.37M derived: sum of 2 quarters · filed 2026-08-10 | $3.11M 10-Q · filed 2025-11-10 | $7.27M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$254.00K 10-Q · filed 2026-08-10 | $3.91M derived: sum of 3 quarters · filed 2026-08-10 | $3.73M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | -$258.00K 10-Q · filed 2026-05-12 | $3.90M derived: sum of 2 quarters · filed 2026-05-12 | $3.72M derived: sum of 3 quarters · filed 2026-05-12 | $7.30M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $3.98M derived: sum of 2 quarters · filed 2026-03-20 | $7.56M derived: sum of 3 quarters · filed 2026-03-20 | $9.58M 10-K · filed 2026-03-20 | |||
| 2024-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.40M derived: sum of 2 quarters · filed 2025-11-10 | $5.42M 10-Q · filed 2025-11-10 | $5.29M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $3.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.60M 10-Q · filed 2025-08-11 | $5.47M derived: sum of 3 quarters · filed 2025-08-11 | $7.04M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-12 | $1.89M derived: sum of 2 quarters · filed 2025-05-12 | $3.46M derived: sum of 3 quarters · filed 2025-05-12 | $8.77M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.44M derived: sum of 2 quarters · filed 2025-03-24 | $6.75M derived: sum of 3 quarters · filed 2025-03-24 | $11.19M 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.88M derived: sum of 2 quarters · filed 2024-11-12 | $11.32M 10-Q · filed 2024-11-12 | $13.03M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $9.75M 10-Q · filed 2024-08-12 | $11.46M derived: sum of 3 quarters · filed 2024-08-12 | $23.51M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $4.44M 10-Q · filed 2024-05-13 | $6.15M derived: sum of 2 quarters · filed 2024-05-13 | $18.20M derived: sum of 3 quarters · filed 2024-05-13 | $19.79M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $13.76M derived: sum of 2 quarters · filed 2024-03-26 | $15.35M derived: sum of 3 quarters · filed 2024-03-26 | $15.26M 10-K · filed 2024-03-26 | |||
| 2022-09-30 | $12.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $13.63M derived: sum of 2 quarters · filed 2023-11-09 | $13.54M 10-Q · filed 2023-11-09 | $12.99M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.50M 10-Q · filed 2023-08-10 | $945.00K derived: sum of 3 quarters · filed 2023-08-10 | $5.49M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$87.00K 10-Q · filed 2023-05-11 | -$641.00K derived: sum of 2 quarters · filed 2023-05-11 | $3.90M derived: sum of 3 quarters · filed 2023-05-11 | $23.37M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.99M derived: sum of 2 quarters · filed 2023-03-22 | $23.46M derived: sum of 3 quarters · filed 2023-03-22 | $24.61M 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $24.01M derived: sum of 2 quarters · filed 2022-11-14 | $25.16M 10-Q · filed 2022-11-14 | $26.67M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $19.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $20.62M 10-Q · filed 2022-08-15 | $22.13M derived: sum of 3 quarters · filed 2022-08-15 | $22.23M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $1.15M 10-Q · filed 2022-05-13 | $2.66M derived: sum of 2 quarters · filed 2022-05-13 | $2.76M derived: sum of 3 quarters · filed 2022-05-13 | -$3.55M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.61M derived: sum of 2 quarters · filed 2022-03-17 | -$4.70M derived: sum of 3 quarters · filed 2022-03-17 | $1.89M 10-K · filed 2022-03-17 | $14.47M 10-K · filed 2021-03-22 | ||
| 2020-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$6.21M derived: sum of 2 quarters · filed 2021-11-12 | $379.00K 10-Q · filed 2021-11-12 | $14.47M 10-Q · filed 2020-11-10 | $242.27K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$6.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $279.00K 10-Q · filed 2021-08-23 | $14.47M 10-Q · filed 2020-08-13 | $142.27K derived: sum of 3 quarters · filed 2021-08-23 | $7.06M derived: sum of 4 quarters · filed 2021-08-23 | ||
| 2020-03-31 | $6.59M 10-Q · filed 2021-05-14 | $6.46M derived: sum of 2 quarters · filed 2021-05-14 | $13.38M derived: sum of 3 quarters · filed 2021-05-14 | $13.30M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | -$136.73K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $6.79M derived: sum of 2 quarters · filed 2021-03-22 | $6.71M derived: sum of 3 quarters · filed 2021-03-22 | $6.59M 10-K · filed 2021-03-22 | |||
| 2019-09-30 | $6.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $6.84M derived: sum of 2 quarters · filed 2020-11-10 | $6.73M 10-Q · filed 2020-11-10 | $8.44M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | -$78.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$195.87K 10-Q · filed 2020-08-13 | $1.52M derived: sum of 3 quarters · filed 2020-08-13 | $1.83M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$117.02K 10-Q · filed 2020-05-15 | $1.60M derived: sum of 2 quarters · filed 2020-05-15 | $1.91M derived: sum of 3 quarters · filed 2020-05-15 | $1.80M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.02M derived: sum of 2 quarters · filed 2020-03-27 | $1.92M derived: sum of 3 quarters · filed 2020-03-27 | $1.81M 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $311.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $206.00K derived: sum of 2 quarters · filed 2019-11-14 | $101.76K 10-Q · filed 2019-11-14 | -$1.35K derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$105.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$209.64K 10-Q · filed 2019-08-14 | -$312.74K derived: sum of 3 quarters · filed 2019-08-14 | $5.63M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$104.24K 10-Q · filed 2019-05-14 | -$207.35K derived: sum of 2 quarters · filed 2019-05-14 | $5.74M derived: sum of 3 quarters · filed 2019-05-14 | $3.96M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | -$103.11K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $5.84M derived: sum of 2 quarters · filed 2019-03-22 | $4.07M derived: sum of 3 quarters · filed 2019-03-22 | $4.99M 10-K · filed 2019-03-22 | |||
| 2017-09-30 | $5.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $4.17M derived: sum of 2 quarters · filed 2018-11-14 | $5.09M 10-Q · filed 2018-11-14 | $23.73M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$851.41K 10-Q · filed 2018-08-13 | $17.78M derived: sum of 3 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $921.70K 10-Q · filed 2018-05-15 | $19.56M derived: sum of 2 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $18.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $23.74M 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | $5.11M 10-Q · filed 2017-11-08 | ||||||
| 2013-09-30 | $7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $9.69M derived: sum of 2 quarters · filed 2013-11-12 | $17.51M 10-Q · filed 2013-11-12 | $17.67M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2013-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $9.83M 10-Q · filed 2013-08-08 | $9.99M derived: sum of 3 quarters · filed 2013-08-08 | $18.78M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2013-03-31 | $7.83M 10-Q · filed 2013-05-10 | $7.98M derived: sum of 2 quarters · filed 2013-05-10 | $16.77M derived: sum of 3 quarters · filed 2013-11-12 | $16.73M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-12-31 | $155.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $8.95M derived: sum of 2 quarters · filed 2013-11-12 | $8.90M derived: sum of 3 quarters · filed 2013-11-12 | $13.82M 10-K · filed 2013-03-15 | |||
| 2012-09-30 | $8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $8.75M derived: sum of 2 quarters · filed 2013-11-12 | $13.67M 10-Q · filed 2013-11-12 | $13.67M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $4.88M 10-Q · filed 2013-08-08 | $4.88M derived: sum of 3 quarters · filed 2013-08-08 | $4.88M derived: sum of 4 quarters · filed 2013-08-08 | |||
| 2012-03-31 | $4.92M 10-Q · filed 2013-05-10 | $4.92M derived: sum of 2 quarters · filed 2013-05-10 | $4.92M derived: sum of 3 quarters · filed 2013-05-10 | $4.92M derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.00 derived: sum of 2 quarters · filed 2013-03-15 | -$1.00 derived: sum of 3 quarters · filed 2013-03-15 | $1.67M 10-K · filed 2013-03-15 | |||
| 2011-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.00 derived: sum of 2 quarters · filed 2012-11-09 | $1.67M 10-Q · filed 2012-11-09 | $2.22M derived: sum of 4 quarters · filed 2012-11-09 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.67M 10-Q · filed 2012-08-09 | $2.22M derived: sum of 3 quarters · filed 2012-08-09 | $2.22M derived: sum of 4 quarters · filed 2012-08-09 | |||
| 2011-03-31 | $1.67M 10-Q · filed 2012-05-09 | $2.22M derived: sum of 2 quarters · filed 2012-05-09 | $2.22M derived: sum of 3 quarters · filed 2012-05-09 | ||||
| 2010-12-31 | $547.84K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $551.79K derived: sum of 2 quarters · filed 2012-03-30 | $17.27M 10-K · filed 2012-03-30 | ||||
| 2010-09-30 | $3.96K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $16.72M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $16.71M 10-Q/A · filed 2011-09-23 | ||||||
| 2009-12-31 | $2.76M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |